Intervacc AB has announced that Strangvac, a vaccine against equine strangles, is now back in stock for delivery in all European markets where the vaccine has been launched. We are very pleased that the Medical Products Agencies around Europe have acted diligently, which has made it possible for Strangvac to be available again for immediate delivery,” commented CEO Jonas Sohlman.
Veterinarian vaccinating a horse.
Complications of Strangles include swelling of lymph nodes restricting the horse's ability to breathe and pus from ruptured lymph nodes draining into horse's lungs causing pneumonia.
© 2016 by Kondrashov MIkhail Evgenevich New window.
The company applied for Special Batch Release (SBR), to allow for the recently manufactured batches to be available for sale. Today, the company can announce that after receiving approval for SBR in all local markets, Strangvac is available for immediate delivery in all markets where the product has been launched.
The procedure and processes, including the Special Batch Release, have been different in different countries, and the time required to make Strangvac available again in the various markets has therefore varied.
Strangvac, a vaccine against equine strangles, is approved for sale and marketing in the EU, as well as in the United Kingdom, Iceland, Norway, and Liechtenstein. It has been launched in Sweden, Denmark, the United Kingdom, France, Germany, Belgium, the Netherlands, Austria, Ireland, Poland, and Italy.
Intervacc AB (publ) is an animal health group that develops vaccines for animals. The company develops and sells vaccines against animal diseases based on the proprietary technology platform with fused recombinant proteins. The Intervacc share is listed on NASDAQ First North Growth Market.
The name "strangles" was coined due to the strangled breathing sounds made by horses with enlarged lymph glands that are characteristic of the disease. Strangles is caused by the bacterium Streptococcus equi that is specific to horses.
A horse that is exposed to Streptococcus equi will begin to show symptoms within two to six days and the characteristic abscessed lymph nodes will develop within one to two weeks after exposure. The lymph nodes rupture and drain and the drainage is highly contagious.
The main complications that can occur include extreme swelling of lymph nodes to the point that airways are compressed and the horse's ability to breathe becomes restricted. In this case, a tracheotomy will be necessary to create an open airway. .
Another complication occurs when pus from the ruptured lymph nodes drains into the horse's lungs, causing a secondary infection of pneumonia. Treatment of the secondary infection becomes necessary and may include a round of antibiotics.
Press release by Intervacc